Kreuter J - Search Results

1

Transport of drugs across the blood-brain barrier by nanoparticles.

Wohlfart S, Gelperina S, Kreuter J. Wohlfart S, et al. Among authors: kreuter j. J Control Release. 2012 Jul 20;161(2):264-73. doi: 10.1016/j.jconrel.2011.08.017. Epub 2011 Aug 18. J Control Release. 2012. PMID: 21872624 Review.

2

Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats.

Ambruosi A, Khalansky AS, Yamamoto H, Gelperina SE, Begley DJ, Kreuter J. Ambruosi A, et al. Among authors: kreuter j. J Drug Target. 2006 Feb;14(2):97-105. doi: 10.1080/10611860600636135. J Drug Target. 2006. PMID: 16608736

3

Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain.

Kreuter J, Hekmatara T, Dreis S, Vogel T, Gelperina S, Langer K. Kreuter J, et al. J Control Release. 2007 Mar 12;118(1):54-8. doi: 10.1016/j.jconrel.2006.12.012. Epub 2006 Dec 20. J Control Release. 2007. PMID: 17250920

4

Use of nanoparticles for cerebral cancer.

Kreuter J, Gelperina S. Kreuter J, et al. Tumori. 2008 Mar-Apr;94(2):271-7. doi: 10.1177/030089160809400220. Tumori. 2008. PMID: 18564616

5

Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers.

Wohlfart S, Khalansky AS, Gelperina S, Maksimenko O, Bernreuther C, Glatzel M, Kreuter J. Wohlfart S, et al. Among authors: kreuter j. PLoS One. 2011 May 6;6(5):e19121. doi: 10.1371/journal.pone.0019121. PLoS One. 2011. PMID: 21573151 Free PMC article.

6

Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier.

Wohlfart S, Khalansky AS, Gelperina S, Begley D, Kreuter J. Wohlfart S, et al. Among authors: kreuter j. J Control Release. 2011 Aug 25;154(1):103-7. doi: 10.1016/j.jconrel.2011.05.010. Epub 2011 May 16. J Control Release. 2011. PMID: 21616104

7

Treatment of glioblastoma with poly(isohexyl cyanoacrylate) nanoparticles.

Wohlfart S, Khalansky AS, Bernreuther C, Michaelis M, Cinatl J Jr, Glatzel M, Kreuter J. Wohlfart S, et al. Among authors: kreuter j. Int J Pharm. 2011 Aug 30;415(1-2):244-51. doi: 10.1016/j.ijpharm.2011.05.046. Epub 2011 May 27. Int J Pharm. 2011. PMID: 21641983

8

Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging.

Watcharin W, Schmithals C, Pleli T, Köberle V, Korkusuz H, Hübner F, Waidmann O, Zeuzem S, Korf HW, Terfort A, Gelperina S, Vogl TJ, Kreuter J, Piiper A. Watcharin W, et al. Among authors: kreuter j. J Control Release. 2015 Feb 10;199:63-71. doi: 10.1016/j.jconrel.2014.11.023. Epub 2014 Dec 10. J Control Release. 2015. PMID: 25499552

9

Potential of surfactant-coated nanoparticles to improve brain delivery of arylsulfatase A.

Schuster T, Mühlstein A, Yaghootfam C, Maksimenko O, Shipulo E, Gelperina S, Kreuter J, Gieselmann V, Matzner U. Schuster T, et al. Among authors: kreuter j. J Control Release. 2017 May 10;253:1-10. doi: 10.1016/j.jconrel.2017.02.016. Epub 2017 Feb 16. J Control Release. 2017. PMID: 28215668

10

Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles.

Kreuter J, Ramge P, Petrov V, Hamm S, Gelperina SE, Engelhardt B, Alyautdin R, von Briesen H, Begley DJ. Kreuter J, et al. Pharm Res. 2003 Mar;20(3):409-16. doi: 10.1023/a:1022604120952. Pharm Res. 2003. PMID: 12669961

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

281 results

Search Page